Furthermore, given the strong positive correlation between AR and EP300/CREBBP in PCa patients (Supplementary Fig. S4a), it is likely that the decrease in AR-gene expression through inhibition of EP300/CREBBP activity is a key contributor to AR signal restriction. This evidence concerns the gene EP300 and posterior cortical atrophy.